ctrl K

/

Search

Popular

KO Coca Cola Company Stock

TSLA Tesla Inc Stock

AMD Advanced Micro Devices Stock

SPY SPDR S&P 500 ETF Trust ETF

NVDA Nvidia Stock

Watchlist Price Alert

Corcept Therapeutics (CORT)

NASDAQ: CORT · Real-Time Price · USD

72.36

1.46 (2.06%)

At close: Jun 17, 2025, 11:47 AM

Insider Trading

Transcripts

Pro Subscription

Upgrade now for unlimited access to all data, tools and no ads.

CORT News

4 days ago - Corcept: Remains A Strong Buy On Recent Weakness And Aggressive Sales Force Hiring - seekingalpha.com
12 days ago - Corcept Presents Results from Phase 2 Study of Dazucorilant in Patients with Amyotrophic Lateral Sclerosis (ALS) at ENCALS 2025 Annual Meeting - businesswire.com
15 days ago - Corcept Presents Pivotal Clinical Data in ASCO Late-Breaker with Simultaneous Publication in The Lancet: Relacorilant Improves Progression-Free and Overall Survival in Patients with Platinum-Resistant Ovarian Cancer - businesswire.com
19 days ago - New Strong Sell Stocks for May 29th - zacks.com
42 days ago - CORT's Q1 Earnings In Line With Estimates, Revenues Lag, Shares Fall - zacks.com
43 days ago - Corcept Therapeutics Incorporated (CORT) Q1 2025 Earnings Call Transcript - seekingalpha.com
43 days ago - Corcept Therapeutics (CORT) Meets Q1 Earnings Estimates - zacks.com
50 days ago - CORCEPT THERAPEUTICS TO ANNOUNCE FIRST QUARTER FINANCIAL RESULTS, PROVIDE CORPORATE UPDATE AND HOST CONFERENCE CALL - businesswire.com
55 days ago - CORCEPT TO PRESENT LATE-BREAKING DATA FROM PIVOTAL PHASE 3 ROSELLA TRIAL OF RELACORILANT IN PLATINUM-RESISTANT OVARIAN CANCER AT ASCO 2025 - businesswire.com
56 days ago - Corcept: Maintaining Strong Buy Even After 4Q Revenue And Earnings Miss - seekingalpha.com

Add to Watchlist

✕

Sections

Stocks
IPOs
ETFs
Blog

Services

Pricing Plan
Discord Bot
Free Newsletter
Get Support

Website

Login
FAQ
Sitemap
Learning Center
Affiliate Program

Company

About
Contact Us
Terms of Use
Privacy Policy
Data Disclaimer
Imprint

© 2025 Stocknear. All rights reserved.